Literature DB >> 27613700

[68Ga]Pentixafor-Positron Emission Tomography/Computed Tomography Detects Chemokine Receptor CXCR4 Expression After Ischemic Stroke.

Jan Stefan Schmid1, Andreas Schirbel1, Andreas K Buck1, Saskia Kropf1, Hans-Jürgen Wester1, Constantin Lapa2.   

Abstract

Entities:  

Keywords:  CXCR4; aphasia; positron emission tomography; small cell lung carcinoma; stroke

Mesh:

Substances:

Year:  2016        PMID: 27613700     DOI: 10.1161/CIRCIMAGING.116.005217

Source DB:  PubMed          Journal:  Circ Cardiovasc Imaging        ISSN: 1941-9651            Impact factor:   7.792


× No keyword cloud information.
  7 in total

Review 1.  Positron Emission Tomography After Ischemic Brain Injury: Current Challenges and Future Developments.

Authors:  Zhuoran Wang; Conrad Mascarenhas; Xiaofeng Jia
Journal:  Transl Stroke Res       Date:  2020-01-14       Impact factor: 6.829

2.  [177Lu]pentixather: Comprehensive Preclinical Characterization of a First CXCR4-directed Endoradiotherapeutic Agent.

Authors:  Margret Schottelius; Theresa Osl; Andreas Poschenrieder; Frauke Hoffmann; Seval Beykan; Heribert Hänscheid; Andreas Schirbel; Andreas K Buck; Saskia Kropf; Markus Schwaiger; Ulrich Keller; Michael Lassmann; Hans-Jürgen Wester
Journal:  Theranostics       Date:  2017-06-11       Impact factor: 11.556

Review 3.  Prospective of 68Ga Radionuclide Contribution to the Development of Imaging Agents for Infection and Inflammation.

Authors:  Irina Velikyan
Journal:  Contrast Media Mol Imaging       Date:  2018-01-04       Impact factor: 3.161

4.  Targeting CXCR4 with [68Ga]Pentixafor: a suitable theranostic approach in pleural mesothelioma?

Authors:  Constantin Lapa; Stefan Kircher; Andreas Schirbel; Andreas Rosenwald; Saskia Kropf; Theo Pelzer; Thorsten Walles; Andreas K Buck; Wolfgang A Weber; Hans-Juergen Wester; Ken Herrmann; Katharina Lückerath
Journal:  Oncotarget       Date:  2017-05-27

5.  A new class of PentixaFor- and PentixaTher-based theranostic agents with enhanced CXCR4-targeting efficiency.

Authors:  Theresa Osl; Alexander Schmidt; Markus Schwaiger; Margret Schottelius; Hans-Jürgen Wester
Journal:  Theranostics       Date:  2020-07-09       Impact factor: 11.556

Review 6.  Advances in Radiopharmaceutical Sciences for Vascular Inflammation Imaging: Focus on Clinical Applications.

Authors:  Kevin Prigent; Jonathan Vigne
Journal:  Molecules       Date:  2021-11-24       Impact factor: 4.411

Review 7.  CXCR4-directed theranostics in oncology and inflammation.

Authors:  Malte Kircher; Peter Herhaus; Margret Schottelius; Andreas K Buck; Rudolf A Werner; Hans-Jürgen Wester; Ulrich Keller; Constantin Lapa
Journal:  Ann Nucl Med       Date:  2018-08-13       Impact factor: 2.668

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.